128 related articles for article (PubMed ID: 29512067)
1. MicroRNA Profiling of Alzheimer's Disease Cerebrospinal Fluid.
Denk J; Jahn H
Methods Mol Biol; 2018; 1750():93-107. PubMed ID: 29512067
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Alzheimer's Disease Micro-RNA Profile in Exosome-Enriched CSF Samples.
Riancho J; Santurtun A; Sánchez-Juan P
Methods Mol Biol; 2019; 2044():343-352. PubMed ID: 31432424
[TBL] [Abstract][Full Text] [Related]
3. CSF microRNA Profiling in Alzheimer's Disease: a Screening and Validation Study.
Dangla-Valls A; Molinuevo JL; Altirriba J; Sánchez-Valle R; Alcolea D; Fortea J; Rami L; Balasa M; Muñoz-García C; Ezquerra M; Fernández-Santiago R; Lleó A; Lladó A; Antonell A
Mol Neurobiol; 2017 Nov; 54(9):6647-6654. PubMed ID: 27738874
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs in Human Cerebrospinal Fluid as Biomarkers for Alzheimer's Disease.
Lusardi TA; Phillips JI; Wiedrick JT; Harrington CA; Lind B; Lapidus JA; Quinn JF; Saugstad JA
J Alzheimers Dis; 2017; 55(3):1223-1233. PubMed ID: 27814298
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-29a Is a Candidate Biomarker for Alzheimer's Disease in Cell-Free Cerebrospinal Fluid.
Müller M; Jäkel L; Bruinsma IB; Claassen JA; Kuiperij HB; Verbeek MM
Mol Neurobiol; 2016 Jul; 53(5):2894-2899. PubMed ID: 25895659
[TBL] [Abstract][Full Text] [Related]
6. Elevated levels of MicroRNA-455-3p in the cerebrospinal fluid of Alzheimer's patients: A potential biomarker for Alzheimer's disease.
Kumar S; Reddy PH
Biochim Biophys Acta Mol Basis Dis; 2021 Apr; 1867(4):166052. PubMed ID: 33412267
[No Abstract] [Full Text] [Related]
7. Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease.
Gui Y; Liu H; Zhang L; Lv W; Hu X
Oncotarget; 2015 Nov; 6(35):37043-53. PubMed ID: 26497684
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA Profile in Patients with Alzheimer's Disease: Analysis of miR-9-5p and miR-598 in Raw and Exosome Enriched Cerebrospinal Fluid Samples.
Riancho J; Vázquez-Higuera JL; Pozueta A; Lage C; Kazimierczak M; Bravo M; Calero M; Gonalezález A; Rodríguez E; Lleó A; Sánchez-Juan P
J Alzheimers Dis; 2017; 57(2):483-491. PubMed ID: 28269782
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Micro-RNA Expression by qPCR on a Microfluidics Platform for Alzheimer's Disease Biomarker Discovery.
Takousis P
Methods Mol Biol; 2018; 1750():283-292. PubMed ID: 29512080
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs in Alzheimer's disease: differential expression in hippocampus and cell-free cerebrospinal fluid.
Müller M; Kuiperij HB; Claassen JA; Küsters B; Verbeek MM
Neurobiol Aging; 2014 Jan; 35(1):152-8. PubMed ID: 23962497
[TBL] [Abstract][Full Text] [Related]
11. Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways.
Cogswell JP; Ward J; Taylor IA; Waters M; Shi Y; Cannon B; Kelnar K; Kemppainen J; Brown D; Chen C; Prinjha RK; Richardson JC; Saunders AM; Roses AD; Richards CA
J Alzheimers Dis; 2008 May; 14(1):27-41. PubMed ID: 18525125
[TBL] [Abstract][Full Text] [Related]
12. Circulating microRNAs in the cerebrospinal fluid of patients with brain diseases.
Machida A; Ohkubo T; Yokota T
Methods Mol Biol; 2013; 1024():203-9. PubMed ID: 23719953
[TBL] [Abstract][Full Text] [Related]
13. Differential Expression of microRNA in Cerebrospinal Fluid as a Potential Novel Biomarker for Alzheimer's Disease.
van Harten AC; Mulders J; Scheltens P; van der Flier WM; Oudejans CB
J Alzheimers Dis; 2015; 47(1):243-52. PubMed ID: 26402772
[TBL] [Abstract][Full Text] [Related]
14. A Customized Quantitative PCR MicroRNA Panel Provides a Technically Robust Context for Studying Neurodegenerative Disease Biomarkers and Indicates a High Correlation Between Cerebrospinal Fluid and Choroid Plexus MicroRNA Expression.
Wang WX; Fardo DW; Jicha GA; Nelson PT
Mol Neurobiol; 2017 Dec; 54(10):8191-8202. PubMed ID: 27900678
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA in Alzheimer's disease: an exploratory study in brain, cerebrospinal fluid and plasma.
Bekris LM; Lutz F; Montine TJ; Yu CE; Tsuang D; Peskind ER; Leverenz JB
Biomarkers; 2013 Aug; 18(5):455-66. PubMed ID: 23822153
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA Expression Levels Are Altered in the Cerebrospinal Fluid of Patients with Young-Onset Alzheimer's Disease.
McKeever PM; Schneider R; Taghdiri F; Weichert A; Multani N; Brown RA; Boxer AL; Karydas A; Miller B; Robertson J; Tartaglia MC
Mol Neurobiol; 2018 Dec; 55(12):8826-8841. PubMed ID: 29603092
[TBL] [Abstract][Full Text] [Related]
17. miRNAs in cerebrospinal fluid associated with Alzheimer's disease: A systematic review and pathway analysis using a data mining and machine learning approach.
Pereira JD; Teixeira LCR; Mamede I; Alves MT; Caramelli P; Luizon MR; Veloso AA; Gomes KB
J Neurochem; 2024 Jun; 168(6):977-994. PubMed ID: 38390627
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid MicroRNA profiling using quantitative real time PCR.
Pacifici M; Delbue S; Kadri F; Peruzzi F
J Vis Exp; 2014 Jan; (83):e51172. PubMed ID: 24514260
[TBL] [Abstract][Full Text] [Related]
19. Detecting Circulating MicroRNAs as Biomarkers in Alzheimer's Disease.
Kenny A; Jimenez-Mateos EM; Calero M; Medina M; Engel T
Methods Mol Biol; 2018; 1779():471-484. PubMed ID: 29886551
[TBL] [Abstract][Full Text] [Related]
20. Preliminary study of hsa-miR-626 change in the cerebrospinal fluid of Parkinson's disease patients.
Qin LX; Tan JQ; Zhang HN; Tang JG; Jiang B; Shen XM; Tang BS; Wang CY
J Clin Neurosci; 2019 Dec; 70():198-201. PubMed ID: 31492481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
